Renaissance Technologies’s Basel Medical BMGL Stock Holding History

Renaissance Technologies’s Portfolio BMGL Stock Details BMGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,208	Closed	-$7.1K	–	3785
2025 Q4	$7.1K	Buy	+1,208	New	+$17.8K	﹤0.01%	3173

Other funds holding BMGL

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

T3 Companies New York $76.8M AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies's BMGL Position: Q1 2026 in Review

Renaissance Technologies sold out of Basel Medical (BMGL) in Q1 2026, closing a stake of 1,208 shares — an estimated $7.1K sold.

Renaissance Technologies first reported a position in BMGL in Q4 2025 and held it in 1 quarter. The position peaked at $7.1K in Q4 2025. 4 funds tracked by Wall St. Rank hold BMGL as of Q1 2026.

Renaissance Technologies reported no remaining Basel Medical position as of Q1 2026 after selling out during the quarter.
Renaissance Technologies sold 1,208 Basel Medical shares in Q1 2026, an estimated $7.1K.
Renaissance Technologies first reported a position in Basel Medical in Q4 2025 and held it in 1 quarter.
Renaissance Technologies's Basel Medical position peaked at $7.1K in Q4 2025.
4 funds tracked by Wall St. Rank held Basel Medical as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.